NanoVibronix, Inc. (NAOV) Financial Analysis & Valuation | Quarter Chart
NanoVibronix, Inc. (NAOV)
NAOVPrice: $1.9
Fair Value: 🔒
🔒score
NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent b... more
NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale o... more
Description
Shares
| Market Cap | $1.51M | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Devices |
| Country | US | CEO | Doron Robert Besser |
| IPO Date | 2015-05-28 | CAGR | 0.29% |
| Employees | 31 | Website | www.nanovibronix.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
NAOV chart loading...
Fundamentals
Technicals
| Enterprise Value | $-6.10M | P/E Ratio | -0.04 |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | — | P/B Ratio | — |
| P/CF Ratio | — | P/FCF Ratio | — |
| EPS | $-51.81 | EPS Growth 1Y | -26.12% |
| EPS Growth 3Y | -78.66% | EPS Growth 5Y | -92.23% |
| Revenue Growth 1Y | -40.35% | Gross Margin | 0.31% |
| Operating Margin | -3.67% | Profit Margin | -1.82% |
| ROE | -0.12% | ROA | -0.07% |
| ROCE | -0.17% | Current Ratio | 0.86 |
| Quick Ratio | 0.67 | Cash Ratio | 0.6 |
| Debt/Equity | 0 | Interest Coverage | -29.87 |
| Altman Z Score | -2.36 | Piotroski Score | 1 |